Snowball logo
logo
6005

Jiangsu Kanion Pharmaceutical Co Ltd

600557 SHG
¥12.08¥0.00  (0%)
Estimate
P/E
22
EPS
0.55
Beta
0.411
Growth
Revenue, YoY
8.66%
Net income, YoY
15.14%
FCF, YoY
-93.78%
Forecast
P/E (FWD)
18.2
EPS (FWD)
0.665
About the company
Ticker
600557
ISIN
CNE000001CL7
Country
China
Sector (GICS)
Healthcare
Jiangsu Kanion Pharmaceutical Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals. The company offers Chinese medicine for anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. It also provides herb extracts and formula granules, well as OEM/ODM services. The company was founded in 1975 and is based in Lianyungang, China.

Frequently asked questions

What sector does Jiangsu Kanion Pharmaceutical Co Ltd (600557) operate in?

Jiangsu Kanion Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Jiangsu Kanion Pharmaceutical Co Ltd (600557) current stock price?

As of the latest data, Jiangsu Kanion Pharmaceutical Co Ltd stock price is CN¥12.08, with a previous close of CN¥12.08.

What is Jiangsu Kanion Pharmaceutical Co Ltd (600557) current market capitalization?

Jiangsu Kanion Pharmaceutical Co Ltd market cap is approximately 6.84 billion.

What is Jiangsu Kanion Pharmaceutical Co Ltd (600557) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.55, and the forward EPS is CN¥0.67.

What is Jiangsu Kanion Pharmaceutical Co Ltd (600557) Price-to-Earnings (P/E) ratio?

Jiangsu Kanion Pharmaceutical Co Ltd current P/E ratio is 21.96, with a forward P/E of 18.17.

Does Jiangsu Kanion Pharmaceutical Co Ltd (600557) pay dividends?

No. Jiangsu Kanion Pharmaceutical Co Ltd does not pay a dividend.

What is Jiangsu Kanion Pharmaceutical Co Ltd (600557) beta (volatility) score?

Jiangsu Kanion Pharmaceutical Co Ltd has a beta of 0.411, indicating lower volatility than the overall market.